With widespread screening and increasingly effective treatments for patients with viral
hepatitis as well as the increasing prevalence of nonalcoholic fatty liver disease, the …

Nonalcoholic fatty liver disease (NAFLD) is tightly associated with obesity and the metabolic
syndrome in the United States and other Western countries. It is also the liver disease most …

Abstract The World Federation for Ultrasound in Medicine and Biology (WFUMB) has
produced these guidelines for the use of elastography techniques in liver disease. For each …

Background The amyloid fibril deposits that cause systemic amyloidosis always contain the
nonfibrillar normal plasma protein, serum amyloid P component (SAP). The drug (R)-1-[6 …

Liver fibrosis is part of the structural and functional alterations in most chronic liver diseases.
It is one of the main prognostic factors as the amount of fibrosis is correlated with the risk of …

In nonalcoholic fatty liver disease, the influence of severity of steatosis on liver stiffness
measurement (LSM) is poorly studied and still debated. We assessed the impact of steatosis …

Liver biopsy is the standard test for the assessment of fibrosis in liver tissue of patients with
chronic liver disease. Recent studies have used a non‐invasive measure of T1 relaxation …

Abstract Background & Aims It is well known that inflammation increases liver stiffness (LS)
in patients with chronic hepatitis C (HCV) and alcoholic liver disease (ALD) independent of …

Two-dimensional shear wave elastography (2-D SWE) is an ultrasound-based elastography
method integrated into a conventional ultrasound machine. It can evaluate larger regions of …

Abstract Background and Aim Liver stiffness measurement (LSM) using transient
elastography (F ibro S can) is a useful tool to assess fibrosis in various chronic liver …